BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
Conditions
- Stage IV Renal Cell Cancer
- Recurrent Renal Cell Cancer
Interventions
- DRUG: BAY 56-3722
- PROCEDURE: enzyme inhibitor therapy
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators